Factors such as rise in prevalence of lung cancer, increasing incidence of chronic respiratory diseases, continuous growth in the healthcare industry, and rising preference towards minimally invasive procedures are expected to drive the growth of the airway stent/lung stent market. However, the complications associated with stents and the availability of alternative treatments are anticipated to impede the growth of this market to a certain extent.
The tracheobronchial stents segment is projected to witness the highest growth during the forecast period.
Based on type, the airway stent/lung stent market is segmented into tracheobronchial and laryngeal stents. The tracheobronchial stents segment is projected to register the highest CAGR during the forecast period. The higher adoption of tracheal and bronchial stents in the treatment of lung cancer and other chronic respiratory diseases is driving the growth of this market.
The hybrid stents segment is expected to grow at the highest rate during the forecast period.
Based on material, the airway stent/lung stent market is segmented into metal, nitinol, and hybrid stents. Hybrid stents are expected to grow at the highest CAGR during the forecast period. These stents eliminate the complications caused by metal or silicone airway/lung stents. Moreover, their larger application as compared to metal & silicone airway/lung stents is driving their adoption among healthcare providers. However, hybrid airway/lung stents are more expensive than other airway/lung stents. This is a major factor limiting their adoption in emerging markets.
The ambulatory surgical centre's segment is expected to register the highest CAGR during the forecast period
Based on the end-user, the airway stent/lung stent market is segmented into hospitals and ambulatory surgical centres. The ambulatory surgical centre's segment is projected to register the highest CAGR during the forecast period. The rising number of ambulatory surgical centres and outpatient surgeries is driving the growth of this segment.
Asia Pacific to witness the highest growth during the forecast period.
Asia Pacific is expected to witness the highest growth during the forecast period (2019 to 2024). Rapidly developing healthcare industry in China & India, growth in aging population, rising incidences of lung cancer & other chronic diseases, rising life expectancy, mounting per capita income, increasing investments by key market players, expansion of private-sector hospitals & reach of ASCs to rural areas, availability of low-cost labor, and the presence of a favorable regulatory environment are supporting the growth of the airway stent/lung stent market in the Asia Pacific.
Break of primary participants was as mentioned below:
- By Company Type - Tier 1-31%, Tier 2-28% and Tier 3-41%
- By Designation - C-level-26%, Director-level-35%, Others-39%
- By Region - North America-23%, Europe-43%, Asia Pacific-17%, Latin America- 9%, Middle East and Africa-8%
The key players operating in the airway stent/lung stent market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.
Research Coverage:
- The report analyzes the airway stent/lung stent market and aims at estimating the market size and future growth potential of this market based on various segments such as type, material, product, end-user, and region.
- The report also includes a product portfolio matrix of various airway stents available in the market.
- The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global airway stent/lung stent market. The report analyzes this market by type, material, product, and end-user.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global airway stent/lung stent market
- Market Development: Comprehensive information on the lucrative emerging markets by type, material, product, and end-user.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global airway stent/lung stent market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global airway stent/lung stent market
Table of Contents
Samples
LOADING...
Companies Mentioned
- Bess Aktiengesellschaft (Bess AG)
- Boston Scientific Corporation
- Cook Group
- E. Benson Hood Laboratories, Inc.
- Efer Endoscopy
- Endo-Flex GmbH
- Merit Medical Systems, Inc.
- Micro-Tech (Nanjing) Co., Ltd.
- Standard Sci. Tech Inc.
- Taewoong Medical Co., Ltd.
Methodology
LOADING...
